Research and Development Team

The Research and Development Team at Harbour BioMed focuses on the discovery and development of innovative biotherapeutics in oncology and immunology, leveraging proprietary transgenic mouse platforms, H2L2 and HCAb, for human antibody discovery. The team’s multidisciplinary expertise spans clinical research, scientific innovation, and engineering, ensuring the advancement of pioneering therapies from concept through clinical trials.